StockWatch
·
Medical/Dental Instruments
BuybackNov 17, 2026, 04:36 PM

iRhythm Announces $100 Million Accelerated Share Repurchase

AI Summary

iRhythm Holdings, Inc. (IRTC) has entered into an accelerated share repurchase (ASR) agreement with JPMorgan Chase Bank for $100 million of its common stock. This ASR is part of the company's previously announced $200 million share repurchase authorization. iRhythm will make an initial payment of $100 million and receive an initial delivery of shares representing approximately 80% of the total expected repurchase. The final settlement is expected by the first quarter of 2027. Following this ASR, approximately $100 million will remain available under the existing authorization. The company plans to fund the ASR using existing cash reserves.

Key Highlights

  • iRhythm enters $100 million accelerated share repurchase (ASR) agreement.
  • ASR is part of a previously announced $200 million share repurchase authorization.
  • Initial payment of $100 million to JPMorgan.
  • Initial delivery of shares expected to be ~80% of total repurchase.
  • Final settlement of ASR expected no later than Q1 2027.
  • Approximately $100 million remaining under share repurchase authorization post-ASR.
  • ASR to be funded with existing cash and cash equivalents.